Medical Devices Then and Now: Why Yesterday’s Innovations Would Fail Today’s Standards

A century ago, medical innovation moved quickly, but regulation did not. Many devices that were widely used in the early 20th century were developed with limited scientific validation, minimal safety testing, and little oversight. While some were grounded in emerging medical understanding, others were built on assumptions that would not withstand modern scrutiny.

Today, medical devices are tightly regulated under frameworks such as the UK Medical Devices Regulations 2002 and the EU Medical Device Regulation (MDR) 2017/745. These require robust clinical evaluation, risk management, quality systems, and post-market surveillance. When viewed through this lens, many historical devices would struggle to reach the market at all.

Take, for example, early electrotherapy machines.

Devices such as “violet ray” machines claimed to treat everything from acne to arthritis using electrical currents delivered through glass electrodes. While electricity does have legitimate medical applications today, these early devices lacked controlled studies, consistent dosing parameters, and clear mechanisms of action. Under modern regulations, manufacturers would be required to demonstrate safety, efficacy, and reproducibility, something these devices could not provide.

Radiation-based treatments are another stark example.

In the early 1900s, products infused with radioactive materials such as radium were marketed for general health and vitality. Devices designed to expose users to low levels of radiation were sold with little understanding of long-term harm. Today, ionising radiation is one of the most tightly controlled areas in healthcare. Any device involving radiation must undergo rigorous risk assessment, dose control validation, and clinical justification. Many of these historical products would be rejected immediately due to unacceptable risk profiles.

Mechanical devices also highlight how far standards have evolved.

Surgical tools from the early 20th century were often effective but lacked the sterility assurance and material standards expected today. Instruments were reused without validated sterilisation processes, increasing infection risk. Modern devices must meet strict requirements for biocompatibility, cleaning validation, and infection control. Even well-intentioned designs would fail without documented evidence of safety across their full lifecycle.

Another major gap lies in claims and intended use.

Historically, many devices were marketed with broad, sometimes exaggerated claims, often without evidence. Today, the intended purpose of a medical device defines its classification and regulatory pathway. Claims must be supported by clinical data, and any ambiguity can lead to reclassification or enforcement action. A device claiming to “cure” multiple unrelated conditions would immediately trigger scrutiny.

Perhaps the most significant difference, however, is accountability.

Modern manufacturers must operate under certified quality management systems, such as ISO 13485, ensuring traceability, consistency, and ongoing monitoring. Post-market surveillance, vigilance reporting, and corrective actions are all mandatory. A device is not simply approved and forgotten, it is continuously assessed throughout its lifecycle.

Looking back, many early medical devices were products of their time, innovative, experimental, and sometimes dangerously optimistic. But under today’s regulatory frameworks, innovation alone is not enough.

Safety, evidence, and accountability are now non-negotiable.

And that shift is exactly what protects patients.

‍